Covestor LTD Cytokinetics Inc Transaction History

Covestor LTD

$150 Million
Q1 2025

A detailed history of Covestor LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Covestor LTD holds 1,914 shares of CYTK stock, worth $59,372. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,914

Previous 166 1053.01%

Holding current value

$59,372

Previous $8,000 862.5%

% of portfolio

0.05%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$40.19 - $51.12 $70,252 - $89,357	1,748 Added 1053.01%	1,914 $77,000
Q4 2024 Feb 13, 2025	SELL	$46.36 - $58.62 $24,339 - $30,775	-525 Reduced 75.98%	166 $8,000
Q3 2024 Nov 01, 2024	SELL	$51.22 - $60.16 $61,668 - $72,432	-1,204 Reduced 63.54%	691 $37,000
Q2 2024 Aug 09, 2024	BUY	$47.86 - $75.05 $82,797 - $129,836	1,730 Added 1048.48%	1,895 $102,000
Q1 2024 May 10, 2024	SELL	$63.75 - $108.06 $21,547 - $36,524	-338 Reduced 67.2%	165 $12,000
Q4 2023 Feb 09, 2024	BUY	$26.88 - $83.49 $8,064 - $25,047	300 Added 147.78%	503 $42,000
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $913 - $1,134	31 Added 18.02%	203 $6,000
Q2 2023 Aug 11, 2023	SELL	$32.62 - $40.75 $32 - $40	-1 Reduced 0.58%	172 $6,000
Q4 2022 Feb 13, 2023	BUY	$35.77 - $51.11 $5,902 - $8,433	165 Added 2062.5%	173 $7,000
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $38 - $54	-1 Reduced 11.11%	8 $0
Q2 2022 Aug 10, 2022	SELL	$33.93 - $48.92 $305 - $440	-9 Reduced 50.0%	9 $0
Q1 2022 May 13, 2022	BUY	$29.74 - $46.0 $29 - $46	1 Added 5.88%	18 $1,000
Q4 2021 Feb 10, 2022	BUY	$34.35 - $46.38 $583 - $788	17 New	17 $1,000

Others Institutions Holding CYTK

# of Institutions

408

Shares Held

127M

Call Options Held

3.66M

Put Options Held

900K

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $2.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account